These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1936474)

  • 1. Effects of metformin on dyslipoproteinemia in non-insulin-dependent diabetes mellitus.
    Schneider J
    Diabete Metab; 1991 May; 17(1 Pt 2):185-90. PubMed ID: 1936474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus.
    Schneider J; Erren T; Zöfel P; Kaffarnik H
    Atherosclerosis; 1990 May; 82(1-2):97-103. PubMed ID: 2193640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
    Hogue JC; Lamarche B; Deshaies Y; Tremblay AJ; Bergeron J; Gagné C; Couture P
    Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pioglitazone on lipids in well controlled patients with diabetes mellitus type 2 -- results of a pilot study.
    Parhofer KG; Otto C; Geiss HC; Laubach E; Göke B
    Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):49-52. PubMed ID: 15662596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).
    Elkeles RS
    Diabete Metab; 1991 May; 17(1 Pt 2):197-200. PubMed ID: 1936476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
    Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
    Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipoproteinaemia in manifest diabetes.
    Manzato E; Crepaldi G
    J Intern Med Suppl; 1994; 736():27-31. PubMed ID: 7986305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.
    Kendall DM; Rubin CJ; Mohideen P; Ledeine JM; Belder R; Gross J; Norwood P; O'Mahony M; Sall K; Sloan G; Roberts A; Fiedorek FT; DeFronzo RA
    Diabetes Care; 2006 May; 29(5):1016-23. PubMed ID: 16644631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
    Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
    J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.
    Nagi DK; Ali VM; Yudkin JS
    Diabet Med; 1996 Aug; 13(8):753-7. PubMed ID: 8862952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of dyslipoproteinemia in patients with diabetes mellitus type 2 (non-insulin-dependent)].
    Leowski J
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):43-7. PubMed ID: 1409042
    [No Abstract]   [Full Text] [Related]  

  • 15. [The phenotypic characteristics and incidence of dyslipoproteinemias in diabetic patients].
    Kiriakov A; Koev D; Kavrykova Iu; Dimova Ia; Ovcharova N; Taneva T; Tinterova Z; Borisova A; Tsoneva G
    Probl Endokrinol (Mosk); 1990; 36(6):25-9. PubMed ID: 2087461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hyperlipoproteinemias.
    Patsch W; Patsch JR; Gotto AM
    Med Clin North Am; 1989 Jul; 73(4):859-93. PubMed ID: 2657266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New aspects of normolipidemic dyslipoproteinemias].
    Mirjana D
    Med Pregl; 2004; 57(11-12):605-9. PubMed ID: 16107011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peripheral circulation and treatment of hyperlipoproteinemias.
    Coffman JD; Rasmussen HM
    Atherosclerosis; 1983 Jan; 46(1):147-59. PubMed ID: 6838691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 3: Hypertriacylglycerolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):116-28. PubMed ID: 1845466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of lipoprotein(a) in patients with well-controlled non-insulin-dependent diabetes mellitus.
    Joven J; Vilella E
    JAMA; 1991 Mar; 265(9):1113-4. PubMed ID: 1825344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.